Michel Demaré

Michel Demaré is the Chairman of AstraZeneca, a prominent global biopharmaceutical company. He has expressed concerns regarding the potential impact of pharmaceutical tariffs, suggesting that they could negatively affect patients and hinder health equity. Demaré's insights reflect broader anxieties within the pharmaceutical industry about the implications of US trade policies on healthcare access.